Increasing daily physical activity may help older adults delay their progression to Alzheimer’s disease (AD), according to research published July 16 in JAMA Neurology.  

The Department of Energy (DOE)’s National Nuclear Security Administration has awarded cooperative agreements for the production of molybdenum-99 (Mo-99) to three U.S. companies, including NorthStar Medical Radioisotopes.

“The differences that we observed indicate the strong possibility that there are sex differences in the structural and functional connections in the brain, which may contribute to women’s increased risk for Alzheimer’s,” said Sepideh Shokouhi, at the Alzheimer’s Association International Conference in Los Angeles.

Industry leaders, including the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the Medical Imaging and Technology Alliance (MITA), hosted a Capitol Hill Briefing July 17, to discuss a bipartisan bill that would expand patient access to diagnostic radiopharmaceuticals.

NorthStar Medical Radioisotopes has finished construction of its new molybdenum-99 (Mo-99) processing facility in Beloit, Wisconsin, the company announced on July 16.

A novel PET radiotracer can help identify changes in the brain’s grey matter that may be indicative of progressive multiple sclerosis (MS), according to a pilot study published in the July issue of Neurology: Neuroimmunology & Neuroinflammation.

PET brain imaging using a new brain imaging paradigm yields preliminary evidence that tobacco smokers may have reduced neuroimmune function compared with non-smokers.

Adding a scan during a patient’s prostate cancer therapy can help personalize treatment, according to research presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI)’s 2019 Annual Meeting in Anaheim, Calif.

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) introduced a host of new officers, including new president Vasken Dilsizian, MD, during its annual meeting in Anaheim, Calif.

The Australian Nuclear Science and Technology Organization (ANSTO)’s new $168 million nuclear medicine facility halted all production after two employees were exposed to an unsafe dose of radiation on Friday, June 21, according to a statement from the organization.

Intravenous (IV) administration of technetium-99m (99mTc) was shown to be a safe, noninvasive way to observe rheumatoid arthritis disease activity, according to a study presented at the 2019 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) in Anaheim, Calif.

University of North Carolina-Chapel Hill researchers have developed a new method for creating radiotracers used in PET imaging. The technique may improve imaging of diseases such as cancer, according to the study published in Science.